MDT

84.7

+0.83%↑

VEEV

231.57

+2.63%↑

A

107.51

+0.6%↑

WBA

10.91

-0.46%↓

CHE

575.22

+1.75%↑

MDT

84.7

+0.83%↑

VEEV

231.57

+2.63%↑

A

107.51

+0.6%↑

WBA

10.91

-0.46%↓

CHE

575.22

+1.75%↑

MDT

84.7

+0.83%↑

VEEV

231.57

+2.63%↑

A

107.51

+0.6%↑

WBA

10.91

-0.46%↓

CHE

575.22

+1.75%↑

MDT

84.7

+0.83%↑

VEEV

231.57

+2.63%↑

A

107.51

+0.6%↑

WBA

10.91

-0.46%↓

CHE

575.22

+1.75%↑

MDT

84.7

+0.83%↑

VEEV

231.57

+2.63%↑

A

107.51

+0.6%↑

WBA

10.91

-0.46%↓

CHE

575.22

+1.75%↑

Search

Smith & Nephew PLC ADR

Open

26.92 0.86

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

26.55

Max

27.03

Schlüsselkennzahlen

By Trading Economics

Einkommen

-16M

198M

Verkäufe

156M

3B

KGV

Branchendurchschnitt

27.34

57.333

Dividendenrendite

2.92

Gewinnspanne

6.638

Angestellte

17,349

EBITDA

197M

717M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+6.23% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

2.92%

2.63%

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-1.6B

11B

Vorheriger Eröffnungskurs

26.06

Vorheriger Schlusskurs

26.92

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

Smith & Nephew PLC ADR Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

28. Apr. 2025, 23:27 UTC

Top News

Woodside Energy Approves $17.5 Billion Louisiana LNG Development -- 2nd Update

28. Apr. 2025, 23:07 UTC

Top News

Woodside Energy Approves $17.5 Billion Louisiana LNG Development -- Update

28. Apr. 2025, 23:03 UTC

Ergebnisse

Waste Management 1Q Profit Falls, Revenue Misses Estimates

28. Apr. 2025, 23:47 UTC

Market Talk

Gold Edges Lower as Traders Assess Mixed Signals From Treasury Secretary Bessent -- Market Talk

28. Apr. 2025, 23:17 UTC

Ergebnisse

Jiangxi Copper 1Q Rev CNY111.61B Vs. CNY122.52B >0358.HK

28. Apr. 2025, 23:17 UTC

Ergebnisse

Jiangxi Copper 1Q Net CNY1.95B Vs. Net CNY1.71B >0358.HK

28. Apr. 2025, 23:13 UTC

Ergebnisse

China Merchants Securities: Higher Interest Income, Fee Income Also Aided 1Q Results>600999.SH

28. Apr. 2025, 23:13 UTC

Ergebnisse

China Merchants Securities 1Q Rev CNY4.71B Vs. CNY4.30B >600999.SH

28. Apr. 2025, 23:13 UTC

Ergebnisse

China Merchants Securities: Gains From Investments in Financial Instruments Supported Results >600999.SH

28. Apr. 2025, 23:13 UTC

Ergebnisse

China Merchants Securities 1Q Net CNY2.31B Vs. Net CNY2.16B >600999.SH

28. Apr. 2025, 23:08 UTC

Ergebnisse

China Longyuan Power: 1Q Power Generation Declined 4.42% on Year>0916.HK

28. Apr. 2025, 23:08 UTC

Ergebnisse

China Longyuan Power 1H Rev CNY8.14B Vs. CNY8.07B >0916.HK

28. Apr. 2025, 23:08 UTC

Ergebnisse

China Longyuan Power 1H Net CNY1.98B Vs. Net CNY2.53B >0916.HK

28. Apr. 2025, 23:04 UTC

Ergebnisse

Huaneng Power: 1Q Net Was Mainly Driven By Decline in Domestic Fuel Costs >0902.HK

28. Apr. 2025, 23:04 UTC

Ergebnisse

Huaneng Power: Decrease in Electricity Tariffs Weighed on Rev >0902.HK

28. Apr. 2025, 23:04 UTC

Ergebnisse

Huaneng Power 1Q Rev CNY60.33B ; Down 7.7% on Year>0902.HK

28. Apr. 2025, 23:04 UTC

Ergebnisse

Huaneng Power 1Q Net CNY4.97B; up 8.2% on Year >0902.HK

28. Apr. 2025, 23:00 UTC

Ergebnisse

Jiangsu Expressway 1Q Rev CNY4.78B Vs. CNY3.47B >0177.HK

28. Apr. 2025, 23:00 UTC

Ergebnisse

Jiangsu Expressway: 1Q Rev Rose Due to Increase in Road Construction Projects >0177.HK

28. Apr. 2025, 23:00 UTC

Ergebnisse

Jiangsu Expressway: Decline in Investment Income, Fall in Revenue Post Asset Disposal Weighed on 1Q Net >0177.HK

28. Apr. 2025, 23:00 UTC

Ergebnisse

Jiangsu Expressway 1Q Net CNY1.21B Vs. Net CNY1.25B >0177.HK

28. Apr. 2025, 22:57 UTC

Top News

Trump Signs Order Requiring Nationwide List of Sanctuary Cities and States -- 8th Update

28. Apr. 2025, 22:55 UTC

Ergebnisse

Tsingtao Brewery: Higher Sales Volumes of Beer Supported Results >0168.HK

28. Apr. 2025, 22:55 UTC

Ergebnisse

Tsingtao Brewery 1Q Net CNY1.71B Vs. Net CNY1.60B >0168.HK

28. Apr. 2025, 22:55 UTC

Ergebnisse

Tsingtao Brewery 1Q Rev CNY10.45B Vs. CNY10.15B >0168.HK

28. Apr. 2025, 22:52 UTC

Ergebnisse

S.F. Holding: Results Supported by Higher Contributions From Logistics Business >002352.SZ

28. Apr. 2025, 22:52 UTC

Ergebnisse

S.F. Holding 1Q Net CNY2.23B Vs. Net CNY1.91B >002352.SZ

28. Apr. 2025, 22:52 UTC

Ergebnisse

S.F. Holding: Cost Controls Also aided 1Q Results >002352.SZ

28. Apr. 2025, 22:52 UTC

Ergebnisse

S.F. Holding 1Q Rev CNY69.85B Vs. CNY65.34B >002352.SZ

28. Apr. 2025, 22:46 UTC

Ergebnisse

Shandong Gold Mining: Increase in Selling Price of Gold Supported Results>600547.SH

Peer-Vergleich

Kursveränderung

Smith & Nephew PLC ADR Prognose

Kursziel

By TipRanks

6.23% Vorteil

12-Monats-Prognose

Durchschnitt 28.47 USD  6.23%

Hoch 30.7 USD

Tief 27 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Smith & Nephew PLC ADR – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

3 ratings

1

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

26.05 / 27Unterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Strong Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.